Everyone has heard of [email protected] Before [email protected], unless there was some natural way, like eating certain types of foods or taking supplements, men who had challenges in the bedroom were faced with not being able to be “intimate” with their partners. Since [email protected] hit the market, many men (and women) have found relief from a very frustrating problem.
It is amazing though that society focused a lot on men’s ability to “perform” but not as much on women and their ability to perform or enjoy themselves…in the bedroom. Now, there is hope for women who have had challenges, including pain, when it came to “intimacy”.
U.S. health regulators have approved a drug made by Japan’s Shionogi & Co to treat women experiencing pain during s*xual intercourse.
According to a report at Huffington Post:
The U.S. Food and Drug Administration approved the drug, Osphena, for a type of pain known as dyspareunia, which is a symptom of vulvar and [email protected] atrophy due to menopause.
Dyspareunia is associated with declining levels of estrogen hormones during menopause. Osphena, known chemically as ospemifene, is a pill that acts like estrogen on [email protected] tissues to make them thicker and less fragile, resulting in a reduction in pain associated with intercourse.
The drug’s label includes a boxed warning, the most severe available, alerting patients to an increased risk of strokes and deep vein thrombosis. Common side effects include hot flashes, [email protected] discharge, muscle spasms and excessive sweating.